- Weintraub WS. Perspective on trends in statin use. JAMA Cardiol. 2017;2(1):11–12. doi:https://doi.org/10.1001/jamacardio.2016.4710.
- Mach F, Ray KK, Wiklund O, et al; European Atherosclerosis Society Consensus Panel. Adverse effects of statin therapy: perception vs. the evidence—focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018;39(27):2526–2539. doi:https://doi.org/10.1093/eurheartj/ehy182.
- Dixit A, Abrudescu A. A case of atorvastatin-associated necrotizing autoimmune myopathy, mimicking idiopathic polymyositis. Case Rep Rheumatol. 2018;2018:5931046. doi:https://doi.org/10.1155/2018/5931046.
- Molokhia M, McKeigue P, Curcin V, Majeed A. Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006. PloS One. 2008;3(6):e2522. doi:https://doi.org/10.1371/journal.pone.0002522.
- Troyanov Y, Landon-Cardinal O, Fritzler MJ, et al. Atorvastatin-induced necrotizing autoimmune myositis: an emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype. Medicine (Baltimore). 2017;96(3):e5694. doi:https://doi.org/10.1097/MD.0000000000005694.
- Hamann PD, Cooper RG, McHugh NJ, Chinoy H. Statin-induced necrotizing myositis—a discrete autoimmune entity within the “statin-induced myopathy spectrum.” Autoimmun Rev. 2013;12(12):1177–1181. doi:https://doi.org/10.1016/j.autrev.2013.07.001.
- Selva-O'Callaghan A, Alvarado-Cardenas M, Pinal-Fernández I, et al. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations. Expert Rev Clin Immunol. 2018;14(3):215–224. doi:https://doi.org/10.1080/1744666X.2018.1440206.
- Casciola-Rosen L, Mammen AL. Myositis autoantibodies. Cur Opin Rheumatol. 2012;24(6):602–608.
- Mammen AL. Statin-associated autoimmune myopathy. N Engl J Med. 2016;374(7):664–669. doi:https://doi.org/10.1056/NEJMra1515161.
Statin-induced necrotizing autoimmune myopathy
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.